close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Rubedo Life Sciences

News headline image
Rubedo Life Sciences Announces Phase 1b Data Showing Reduction in Skin Epigenetic Age and Systemic Inflammatory Biomarkers Following Four-Week Treatment with RLS-1496
From Rubedo Life Sciences
Via Business Wire
News headline image
Rubedo Life Sciences Announces Clinical Development Plans for Lead Candidate RLS-1496, a First-in-Class GPX4 Modulator Targeting Aging Cells and Surrounding Tissues
From Rubedo Life Sciences
Via Business Wire
News headline image
Rubedo Life Sciences Appoints Former Allergan Executive and Biotechnology Veteran Dr. Frederick Beddingfield III as CEO
From Rubedo Life Sciences
Via Business Wire
News headline image
Rubedo Life Sciences Announces European Expansion Ahead of First Clinical Trial
From Rubedo Life Sciences
Via Business Wire
News headline image
Rubedo Life Sciences and Beiersdorf Announce Multi-Year Partnership to Pioneer New Skin Care Products that Address Cellular Aging
From Rubedo Life Sciences
Via Business Wire
News headline image
Rubedo Life Sciences Closes $40M Series A Financing Led by Khosla Ventures and Ahren Innovation Capital
From Rubedo Life Sciences
Via Business Wire
News headline image
Rubedo Life Sciences Announces Nomination of First-in-Class Disease-Modifying Candidate RLS-1496 in Dermatology at LSX World Congress 2023
From Rubedo Life Sciences
Via Business Wire
News headline image
Rubedo Life Sciences Presents In Vivo Efficacy Data Targeting Senescence Cells to Treat Dermatological Diseases
From Rubedo Life Sciences
Via Business Wire
News headline image
Rubedo Life Sciences Awarded $1.45M in Funding From the California Institute for Regenerative Medicine (CIRM) for Idiopathic Pulmonary Fibrosis Program
From Rubedo Life Sciences
Via Business Wire
News headline image
Rubedo Life Sciences Expands Leadership Team with Ali Siam as Chief Business Officer and Ofir Moreno, Ph.D., as SVP of Drug Discovery
From Rubedo Life Sciences
Via Business Wire
News headline image
Rubedo Life Sciences Announces Expansion of Scientific Advisory Board
From Rubedo Life Sciences
Via Business Wire
News headline image
Rubedo Life Sciences Establishes Collaboration with Cedars-Sinai Medical Center to Advance Idiopathic Pulmonary Fibrosis Program
From Rubedo Life Sciences
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at /week.